Hypoalbuminemia Hypoalbuminemia means low blood albumin levels. This can be caused by: •
Liver disease;
cirrhosis of the liver is most common • Excess excretion by the
kidneys (as in
nephrotic syndrome) • Excess loss in bowel (protein-losing enteropathy, e.g.,
Ménétrier's disease) • Burns (plasma loss in the absence of skin barrier) • Redistribution (hemodilution [as in
pregnancy], increased vascular permeability or
decreased lymphatic clearance) • Acute disease states (referred to as a negative
acute-phase protein) •
Malnutrition and wasting • Mutation causing analbuminemia (very rare) •
Anorexia nervosa (most common cause in adolescents) In clinical medicine, hypoalbuminemia significantly correlates with a higher mortality rates in several conditions such as heart failure, post-surgery, COVID-19.
Hyperalbuminemia Hyperalbuminemia is an increased concentration of albumin in the blood. Hyperalbuminemia has also been associated with high protein diets.
Medical use Human albumin solution (HSA) is available for medical use, usually at concentrations of either 5 or 25%. Human albumin is often used to replace lost fluid and help restore blood volume in trauma, burns and surgery patients. There is no strong medical evidence that albumin administration (compared to saline) saves lives for people who have
hypovolaemia or for those who are critically ill due to burns or
hypoalbuminaemia. It is also not known if there are people who are critically ill that may benefit from albumin. In
acoustic droplet vaporization (ADV), albumin is sometimes used as a
surfactant. ADV has been proposed as a cancer treatment by means of
occlusion therapy. Human serum albumin may be used to potentially reverse drug/chemical toxicity by binding to free drug/agent. Human albumin may also be used in treatment of decompensated cirrhosis. Human serum albumin has been used as a component of a
frailty index. ==Glycation==